| Product Code: ETC338484 | Publication Date: Aug 2023 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India pharmaceuticals market import shipment depicted a steady growth trajectory with a CAGR of 5.4% from 2020 to 2024. The growth rate between 2023 and 2024 accelerated to 6.3%, indicating an expanding market with increasing momentum over the years.
The pharmaceuticals market in India is a cornerstone of the healthcare sector, catering to both domestic and international demand. With a vast patient population and a robust pharmaceutical manufacturing base, India is a key player in the global pharmaceutical industry. However, challenges include the need for regulatory compliance, ensuring drug safety and quality, and adapting to shifts in global healthcare trends. The industry`s future lies in research and development, innovative drug discovery, and the ability to provide affordable yet effective healthcare solutions.
The pharmaceuticals market in India is influenced by several drivers. The country`s large population, increasing healthcare needs, and rising middle-class incomes are driving the demand for pharmaceutical products. India role as a global hub for generic drug manufacturing has also contributed to the market`s growth. Furthermore, investments in research and development, as well as government initiatives to promote the pharmaceutical industry, are encouraging innovation and expansion. The COVID-19 pandemic has underscored the importance of a robust healthcare system, further emphasizing the significance of the pharmaceuticals market.
The pharmaceuticals market in India is robust, driven by factors such as a large patient population and growing healthcare needs. Nonetheless, challenges involve regulatory complexities, the need for constant innovation, pricing pressures, and the quest for affordable and accessible healthcare solutions. Striking a balance between research and development costs, quality healthcare, and profitability remains a significant challenge for pharmaceutical companies.
The India pharmaceuticals market is a vital component of the healthcare sector, supplying essential medications to a vast population. The market experienced disruptions during the pandemic, including supply chain challenges, increased demand for specific drugs, and shifts in healthcare priorities. The crisis highlighted the importance of domestic manufacturing and R&D capabilities. The pharmaceutical sector`s resilience and its role in combating the pandemic reinforced the need for strategic investments, innovation, and global collaborations. The market`s outlook remains optimistic as healthcare systems adapt and pharmaceutical companies continue to play a critical role in public health.
The India pharmaceuticals market is a robust sector driven by the country`s large population and increasing healthcare needs. Key players in this market include renowned companies such as Sun Pharmaceutical Industries, Dr. Reddy`s Laboratories, and Cipla. These companies manufacture and distribute a wide range of pharmaceutical products, including generics and innovative drugs. Challenges in this market involve stringent regulations, pricing pressures, and the need for continuous research and development to stay competitive globally.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pharmaceuticals Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 India Pharmaceuticals Market - Industry Life Cycle |
3.4 India Pharmaceuticals Market - Porter's Five Forces |
3.5 India Pharmaceuticals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 India Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2021 & 2031F |
3.9 India Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
4 India Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing population and healthcare needs in India |
4.2.2 Growing prevalence of chronic diseases and lifestyle-related conditions |
4.2.3 Government initiatives to promote healthcare access and affordability |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment and pricing controls |
4.3.2 Competition from generic and counterfeit drugs |
4.3.3 Limited healthcare infrastructure and distribution challenges |
5 India Pharmaceuticals Market Trends |
6 India Pharmaceuticals Market, By Types |
6.1 India Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Pharmaceuticals Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 India Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2021-2031F |
6.1.4 India Pharmaceuticals Market Revenues & Volume, By Biologics, 2021-2031F |
6.2 India Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 India Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.2.3 India Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2021-2031F |
6.2.4 India Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.3 India Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Pharmaceuticals Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 India Pharmaceuticals Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 India Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.4 India Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 India Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2021-2031F |
6.4.3 India Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2021-2031F |
6.5 India Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 India Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2021-2031F |
6.5.3 India Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2021-2031F |
7 India Pharmaceuticals Market Import-Export Trade Statistics |
7.1 India Pharmaceuticals Market Export to Major Countries |
7.2 India Pharmaceuticals Market Imports from Major Countries |
8 India Pharmaceuticals Market Key Performance Indicators |
8.1 Research and development expenditure in the pharmaceutical sector |
8.2 Adoption of digital health technologies in pharmaceutical manufacturing and distribution |
8.3 Number of partnerships and collaborations between pharmaceutical companies and healthcare providers |
8.4 Investment in pharmaceutical manufacturing capacity and technologies |
8.5 Percentage of the population covered by health insurance or government healthcare schemes |
9 India Pharmaceuticals Market - Opportunity Assessment |
9.1 India Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 India Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2021 & 2031F |
9.5 India Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10 India Pharmaceuticals Market - Competitive Landscape |
10.1 India Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 India Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |